(Corrects amount of overturned verdict in headline and paragraph 1, adds information on reduced verdict in paragraph 3)
By Blake Brittain
WASHINGTON, May 28 (Reuters) – A U.S. appeals court on Thursday overturned a $59 million verdict that medical device maker Insulet won against Korean rival EOFlow for allegedly stealing trade secrets related to its insulin-pump technology.
The Washington-based U.S. Court of Appeals for the Federal Circuit reversed the verdict after finding that Insulet had waited too long to bring its lawsuit.
A federal jury in Massachusetts had determined in 2024 that EOFlow owed $452 million in damages for misappropriating Insulet trade secrets to create a competitor to Insulet’s Omnipod, a wearable insulin pump for diabetes patients. A Massachusetts judge reduced the award to $59.4 million last year.
(Reporting by Blake Brittain in Washington)
Brought to you by www.srnnews.com